Mandy Kader Kondé

Chair of the Guinea Ebola Research Commission, Co-Principal Investigator Ebola rVSV Vaccine Trail, Executive Director FOSAD & CEFORPAG at Center of Research on Priority Diseases

Areas of expertise

- Public and Community Health
- Mother and Child Health
- Disease Prevention and Control
- Clinical Research

Major works

Ana Maria Henao-Restrepo, …., Mandy Kader Kondé, et al. : Efficacy and effectiveness of an rVSV-vectored vaccine inpreventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). www.thelancet.com Published online December 22, 2016, http://dx.doi.org/10.1016/S0140-6736(16)32621-6

About me

Professor Mandy Kader Kondé is the Chair of the Foundation on Health & Sustainable Development (FOSAD) and Executive Director of the Center of Research on priority diseases (CEFORPAG) in Guinea Conakry. He has over 40 years of experience cutting across academia, clinical trials, public health management, and epidemic preparedness and response around the world. He played a crucial role in the 2014-2016 Ebola outbreak, chairing the Guinea Ebola Research Commission. He served as co-principal investigator for several clinical trials including the Guinea rVSV Ebola vaccine Phase 3 trial. He is currently member of COVID-19 Guinea Scientific Council and he’s the Africa lead for IDRC Project “Strengthening Ebola Research Ethics” with Western University (Ontario Canada).